Frank Stonebanks is the founder of Renibus Therapeutics. Renibus Therapeutics has raised $72M in total funding. Latest round: Series A.
Frank Stonebanks is the Chief Executive Officer of Renibus Therapeutics, a clinical-stage biotech company specializing in cardiorenal diseases. He assumed the CEO role in February 2022, bringing over 25 years of experience in healthcare and venture capital.
Full founder directory · Investor directory · Company funding database · Fundraising library